Cameron Santoro is an associate editor for The American Journal of Managed Care® (AJMC®), AJMC.com, and The Center for Biosimilars®.
FDA Expands Dupilumab Approval as First New Biologic for Bullous Pemphigoid
June 20th 2025Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease remission and significantly improving symptoms like itch and disease severity in adults.
Topical Ruxolitinib Emerges as Promising Therapy for Diverse Inflammatory Skin Conditions
June 17th 2025Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic conditions.
Alzheimer Disease and Related Dementias Cause Surging Economic Burden for Minoritized Communities
June 5th 2025African American and Latino older adults with Alzheimer disease and related dementias and their families are likely to face disproportionately high burdens, primarily associated with unpaid caregiving, suggesting the need for policies that may reduce economic burdens for all US residents.
Strategies to Address Veteran Health Disparities Beyond the Battlefield
May 30th 2025Despite their profound sacrifices, veterans and active military members disproportionately face significant physical and mental health issues stemming from their service, with many struggling to access the affordable and comprehensive care they need.
Pediatric Hidradenitis Suppurativa Linked to Gut Microbiome Dysregulation, Mental Health Connections
May 28th 2025Significant differences in gut microbiome composition were found among pediatric patients with hidradenitis suppurativa, suggesting further investigation surrounding gut microbiome dysregulation.
Future of Vitiligo Treatment: Emerging Therapies, Impact on Quality of Life
May 28th 2025Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted and effective treatments, though further research is needed to confirm their safety, efficacy, and optimal use.
The Argument Against Routine Antibiotics for Patients With Nonsevere COVID-19
May 19th 2025Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm associated with routine early antibiotic treatment, supporting antibiotic stewardship to limit unnecessary use.
Empowering Women's Health: Integrated Care and Education With Jessica Horwitz, MPH, FNP-C
May 16th 2025Jessica Horwitz, MPH, FNP-C, emphasizes the importance of accessible preventive care and health education, the interconnectedness of mental and physical well-being, and the need for women, providers, and policymakers to prioritize comprehensive and depoliticized women's health care.
Addressing Intersectionality in Women's Health: An Interview With Jessica Horwitz, MPH, FNP-C
May 15th 2025Jessica Horwitz, MPH, FNP-C, highlighted the crucial need for public health professionals and health care providers to address the intersectionality of women's health by acknowledging diverse experiences and ensuring equitable, coordinated care that goes beyond physical health.
Depoliticizing and Prioritizing Comprehensive Women's Health: Jessica Horwitz, MPH, FNP-C
May 14th 2025Jessica Horwitz, MPH, FNP-C, advocated leveraging Women's Health Week to promote comprehensive and depoliticized women's health care, destigmatizing pelvic floor health, and integrating mental health into primary care.